MEDICAL COSTS COMPARISON BETWEEN INTERNAL FIXATION AND ARTHOPLASTY IN PATIENTS WITH HIP FEMORAL NECK FRACTURES

Author(s)

Song X1, Shi N1, Yurgin N2, Varker H1, Dent R2, Bhandari M31Truven Health Analytics, Cambridge, MA, USA, 2Amgen Inc., Thousand Oaks, CA, USA, 3McMaster University, Hamilton, ON, Canada

OBJECTIVES: Surgery is common after a hip fracture.  Two surgical options are arthoplasty (AR) (i.e., hip replacement) or internal fixation (IF) (i.e., fixing the patient’s hip).  Previous research suggests that AR is less costly than IF because IF failure rate is high.   This retrospective cohort study compared medical costs between IF and AR in patients with hip fractures of the femoral neck in a large US population. METHODS: Patients ≥50 years with IF or AR performed within 7 days of a hip femoral  neck fracture occurring between 7/1/2002 and 1/31/2010 were identified from the Marketscan database. Details on the specific location of the fracture line within the femoral neck were not available. All patients had continuous insurance coverage for 6 months prior to (pre-period) and 60 days following (post-period) the surgery date (index date). Patients were followed from surgery date up to 18 months or until death, end of continuous enrollment, or end of study period (3/31/2010), whichever came first. Generalized linear models on costs were used to adjust different patient demographic and clinical characteristics. RESULTS: A total of 41,789 patients (mean age 80 years) were identified (60% IF and 40% AR patients). Post-period mean monthly costs were similar between the two cohorts ($4344 for IF vs. $4401 for AR, p=0.339). Costs were the highest in the first month when the surgery occurred and the IF cohort had lower cost than the AR cohort ($22,707 vs. $25,646, p<0.001). No statistically significant differences were found in the multivariate adjusted total mean monthly costs. The AR cohort had slightly higher inpatient costs ($2642 for AR vs. $2469 for IF, p<0.001) but lower outpatient costs ($1463 for AR vs. $1653 for IF, p<0.001). CONCLUSIONS: In this large population, both IF and AR interventions result in significant and similar health care costs.

Conference/Value in Health Info

2012-11, ISPOR Europe 2012, Berlin, Germany

Value in Health, Vol. 15, No. 7 (November 2012)

Code

PSU11

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Musculoskeletal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×